FR2706891B1 - - Google Patents

Info

Publication number
FR2706891B1
FR2706891B1 FR9406817A FR9406817A FR2706891B1 FR 2706891 B1 FR2706891 B1 FR 2706891B1 FR 9406817 A FR9406817 A FR 9406817A FR 9406817 A FR9406817 A FR 9406817A FR 2706891 B1 FR2706891 B1 FR 2706891B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9406817A
Other languages
French (fr)
Other versions
FR2706891A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon Group SpA
Zambon SpA
Original Assignee
Zambon Group SpA
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA, Zambon SpA filed Critical Zambon Group SpA
Publication of FR2706891A1 publication Critical patent/FR2706891A1/fr
Application granted granted Critical
Publication of FR2706891B1 publication Critical patent/FR2706891B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR9406817A 1993-06-21 1994-06-03 Expired - Lifetime FR2706891B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001324A IT1264855B1 (it) 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici

Publications (2)

Publication Number Publication Date
FR2706891A1 FR2706891A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-12-30
FR2706891B1 true FR2706891B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-10-20

Family

ID=11366435

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9406817A Expired - Lifetime FR2706891B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-21 1994-06-03

Country Status (12)

Country Link
US (1) US5510385A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0710749A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE1007193A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2125644C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH686866A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE4420858A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2099022B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2706891B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2279251A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1264855B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL9401006A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE9402156L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0740935A4 (en) * 1994-02-24 1999-06-16 Otsuka Pharma Co Ltd ANALGETIC ACTIVITY AMPLIFIER
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
EP1438030A2 (en) * 2001-09-28 2004-07-21 McNEIL-PPC, INC. Modified release dosage forms
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
KR101113005B1 (ko) 2003-03-21 2012-02-24 맥네일-피피씨, 인코포레이티드 비-스테로이드계 항염증성 약물 투여법
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
MXPA06014185A (es) * 2004-06-07 2007-04-16 Strides Arcolab Ltd Composicion farmaceutica que contiene una solucion estable y clara de medicamento anti-inflmatorio en capsulas de gelatina blanda, y proceso para producirlo.
US20050281876A1 (en) * 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
MX2009000145A (es) * 2006-06-30 2009-01-23 Mcneil Ppc Inc Capsulas duras llenas con liquido que contiene ibuprofeno.
KR20090088913A (ko) 2006-11-21 2009-08-20 맥네일-피피씨, 인코포레이티드 개질된 방출형 진통 현탁제
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
CN101784262A (zh) 2007-08-15 2010-07-21 麦克内尔-Ppc股份有限公司 速释和缓释的布洛芬给药方案
US8143314B1 (en) * 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
CN101390844B (zh) * 2007-09-23 2011-11-09 天津医科大学 精氨酸布洛芬片剂及其制备方法
CN101265178A (zh) * 2008-04-25 2008-09-17 北京阜康仁生物制药科技有限公司 一种右旋布洛芬的氨基酸盐及其药用组合物
CN108191846B (zh) * 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
TW201038296A (en) * 2009-04-27 2010-11-01 Aplicaciones Farmacodinamicas S A Lab De Ibuprofen lysinate oral suspension
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
ES2519592T3 (es) * 2011-11-17 2014-11-07 Zambon S.P.A. Composiciones sólidas farmacéuticas que contienen sales de ibuprofeno
RU2609836C2 (ru) 2012-02-07 2017-02-06 МакНЕЙЛ-ППС, ИНК. Быстроразрушающиеся таблетки с покрытием
US20140079796A1 (en) 2012-09-18 2014-03-20 Mcneil-Ppc, Inc. Sustained Release Oral Dosage Forms Comprising Low Melting Propionic Acid Derivative Particles
HK1212886A1 (zh) 2012-09-18 2016-06-24 Mcneil-Ppc, Inc. 用於口服剂型的低熔点丙酸衍生物粒子
MA45713A (fr) 2016-07-19 2019-05-29 Johnson & Johnson Consumer Inc Comprimés ayant des régions revêtues discontinues
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CA3043487A1 (en) 2016-11-21 2018-05-24 Just Biotherapeutics, Inc. Aflibercept formulations and uses thereof
WO2019099965A1 (en) 2017-11-20 2019-05-23 Just Biotherapeutics, Inc. Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
EP3743042A1 (en) 2018-01-22 2020-12-02 Johnson & Johnson Consumer Inc. Perforated capsules
US20210378968A1 (en) 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
EP0424028B1 (en) * 1989-10-17 1995-09-27 Merck & Co. Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset hastened enhanced analgesics
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
ES2093192T3 (es) * 1991-03-22 1996-12-16 Merck & Co Inc Formulacion farmaceutica con elevado contenido de lisinato de ibuprofeno.
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations

Also Published As

Publication number Publication date
ES2099022A1 (es) 1997-05-01
ES2099022B1 (es) 1998-01-16
SE9402156D0 (sv) 1994-06-20
US5510385A (en) 1996-04-23
CA2125644A1 (en) 1994-12-22
JPH0710749A (ja) 1995-01-13
CA2125644C (en) 2007-06-05
SE9402156L (sv) 1994-12-22
GB2279251A (en) 1995-01-04
FR2706891A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-12-30
DE4420858A1 (de) 1994-12-22
ITMI931324A0 (it) 1993-06-18
GB9410987D0 (en) 1994-07-20
BE1007193A5 (fr) 1995-04-18
CH686866A5 (it) 1996-07-31
ITMI931324A1 (it) 1994-12-21
IT1264855B1 (it) 1996-10-17
NL9401006A (nl) 1995-01-16

Similar Documents

Publication Publication Date Title
FR09C0038I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2706891B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN181717B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2701905B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0721427A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK0611885T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK2193D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2700841B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK0645781T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2706896B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0707697A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2706741B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2706733B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK46993D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN180884B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSDI930115S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN180376B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSDI930131S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN183108B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN187407B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN180629B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSDI930105S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN179845B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN180979B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN182324B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
TP Transmission of property